All stocks / RGBP
Regen BioPharma Inc RGBP
Regen BioPharma (RGBP): shares outstanding up 5209% in a year, convertible notes mentioned in an 8-K in November 2026, a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- REGEN BIOPHARMA INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- 09:35:00
- Website
- www.regenbiopharma.com
News headlines
The financial report, and what it means
Annual figures to 2025-09-30- Revenue
- $236,561
- Net loss
- ($1,274,502)
It spends more than it earns
Under strainCustomers paid it $236,561 in the year. It lost $1.3 million. For every $1 that came in, about $6.39 went out.
- Cash and cash equivalents
- $69,555
- Net cash used in operating activities
- ($383,591)
The cash could run out soon
Under strainIt had $69,555 in the bank and used about $31,966 a month. At that pace the money lasts about 2 months unless it borrows or sells more shares.
- Total assets
- $274,628
- Total liabilities
- $6,555,811
It owes more than it owns
Under strainEverything the company owns adds up to $274,628. Its debts and unpaid bills add up to $6.6 million. That is about $23.87 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
8-K filed 2026-11-02 mentions: convertible note, equity line.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
Filed NT 10-Q on 2026-08-13: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding rose from 31,554,704 (2025-06-30) to 1,675,277,503 (2026-08-12), up 5209%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 1,675,277,503 shares as of 2026-08-12: 1,675,277,503 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about RGBP
Does RGBP file reports with the SEC?
Yes. Regen BioPharma files with the SEC under company number 0001589150. The most recent filing we hold is a 8-K dated 2026-11-02.
Source recordHow many RGBP shares are outstanding?
1,675,277,503 shares as of 2026-08-12, as reported to the SEC. That is up 5209% from 31,554,704 on 2025-06-30.
Source recordHas RGBP filed reports late?
Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-Q on 2026-08-13. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Regen BioPharma making money?
Customers paid it $236,561 in the year. It lost $1.3 million. For every $1 that came in, about $6.39 went out. (Annual figures to 2025-09-30. Facts from the company's own report, not a recommendation.)
Source record